Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • Dietetic treatment  (2)
  • Whole body counter  (2)
  • 1
    Electronic Resource
    Electronic Resource
    Springer
    European journal of pediatrics 116 (1974), S. 95-114 
    ISSN: 1432-1076
    Keywords: Non-ketotic hyperglycinaemia ; Dietetic treatment ; Histologic changes of brain ; Liver
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Zusammenfassung Es wird über eine Patientin mit einer nichtketotischen Hyperglycinämie berichtet, die 2 Jahre lang mit einer vollsynthetischen Kost aus einem Aminosäurengemisch, Mineralien, Glucose, Fett und Vitaminzusätzen behandelt wurde. Die diätetische Behandlung sowie Zusatz von Natrium-Benzoat zur Nahrung führten nur kurzfristig zu einem Absinken der Plasma-Glycin-Konzentrationen. Nach Anreicherung der Nahrung mit L-Methionin in einer Dosierung von 300 mg/kg KG/die zeigten sich zwar deutlich niedrigere Glycinspiegel, gleichzeitig kam es aber zu einer exzessiven Hypermethioninämie. L-Methionin-Gabe in Dosierungen von 150–200 mg/kg KG hatten keinen Einfluß auf die Höhe des Plasma-Glycin-Spiegels. Die körperliche Entwicklung des Kindes unter Diätbehandlung war altersentsprechend. Ein Einfluß auf die geistige Entwicklung wurde nicht bemerkt, es bestand aber bereits zu Beginn der Behandlung das Bild einer Decrebrierung. Pathologisch-histologisch zeigten sich Veränderungen des ZNS in Form von Markscheidenreifungshemmung und einer spongiösen Degeneration der weißen Substanz in Großhirn, Kleinhirn und Rückenmark sowie Einlagerungen von doppeltbrechenden Kristallen. In der grauen Substanz waren keine groben Alterationen nachweisbar. Im Bereich des peripheren Nervensystems fanden sich keine Markscheidenausfälle und keine doppeltbrechenden Kristalle. Die Leber zeigte eine leichte Vacuolisierung der Leberzellen und eine starke Einlagerung von doppeltbrechenden Kristallen in Parenchymzellen und Makrophagen.
    Notes: Abstract A girl with non-ketotic hyperglycinaemia was treated for 2 years with a synthetic diet consisting of a glycine- and serine-free amino-acid mixture, glucose, fat, minerals, and vitamins. The addition of sodium benzoate to this diet resulted in only a temporary decrease of the plasma glycine concentration. Addition of 300 mg methionine/kg/day led to a marked reduction of glycine in the plasma but also to an excessive increase of the methionine plasma concentration. L-methionine at a lower dose did not influence the plasma glycine level. During the dietary treatment an almost normal gain of body weight was observed, though the psychomotor development was not influenced. Post mortem the following changes were noted: 1. reduced myelination of the white matter; 2. spongiform alterations of the white matter of the cerebrum, the cerebellum, and the spinal cord; 3. inclusions of birefringent crystals in liver and brain. The grey matter of the cerebrum did not show any marked alterations. In peripheral nerves no areas of demyelination or inclusions of crystals were found.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    Electronic Resource
    Electronic Resource
    Springer
    European journal of pediatrics 118 (1975), S. 249-258 
    ISSN: 1432-1076
    Keywords: Primary hypomagnesemia ; Hypocalcemia ; Intestinal absorption ; Magnesium ; Whole body counter
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Zusammenfassung Der klinische Verlauf zweier Patienten mit primärer Hypomagnesämie wird beschrieben. Bei einem Patienten, einem 5 Monate alten Säugling, wurden Magnesiumretention,-resorption,-Stuhlausscheidung und-Clearance gemessen. Die Retention (2,8%) und Resorption (7,8%) von Magnesium28 war deutlich erniedrigt im Vergleich zu Kontrollpersonen, die durchschnittlich 25% retinierten und 28% absorbierten. Zwischen den Retentionswerten der Eltern und Verwandten und denen der gesunden Erwachsenen bestand kein Unterschied. Der untersuchte Patient wurde erfolgreich mit Trimagnesiumdicitrat, entsprechend einer Dosis von 1,75 g Magnesium, behandelt.
    Notes: Abstract The clinical course of 2 patients with primary hypomagnesemia is reported. In one male patien, 5 months old, measurements of magnesium retention, intestinal absorption, fecal excretion and renal clearance were performed. The retention (2.8%) and absorption (7.8%) of 28-Mg were markedly reduced in comparison to controls (average retention 25% and average absorption 28%). The retention values of the parents and other relatives did not differ from those of healthy adults. The examined patient was successfully treated with trimagnesium dicitrate containing 1.75 g magnesium per day.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    ISSN: 1432-1076
    Keywords: Acrodermatitis enteropathica ; Zinc ; Malabsorption ; Therapy ; Zinc retention ; Zinc elimination ; Whole body counter
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Zusammenfassung Bei 3 Patienten mit Akrodermatitis enteropathica wurde mit Hilfe der Ganzkörpermessung nach oraler Applikation von 65Zn eine verminderte intestinale Zinkresorption gedunden. Dagegen war die Zinkelimination aus dem Körper normal. Die Zinkkonzentration im Serum war bei den Patienten stark erniedrigt. Alle klinischen Symptome verschwanden nach sehr hohen oralen Zinkdosen. Diese Befunde sprechen um so mehr für eine ursächliche Rolle des Zinks in der Pathogenese der Akrodermatitis enteropathica, als bei dieser Krankheit ultrastrukturelle Veränderungen in den Panethschen Zellen nachzuweisen sind [12], die auch beim Zinkmangel der Ratten gefunden wurden [Beitr. Path. 145, 336 (1972)].
    Notes: Abstract The intestinal resorption of zinc using 65ZnCl2 was estimated in 3 patients with acrodermatitis enteropathica, 2 healthy controls, and 3 heterozygotes. After oral application of 65Zn the whole body activity was measured by a whole body counter for 34 days. The 65Zn resorption of the patients amounted to 16, 42 and 30% of the applied dose, whereas the resorption values of the heterozygotes and the controls were in the range of 58 and 77%. The elimination of 65Zn from the body amounted to about 0.7% of the applied dose with no difference between controls and patients with acrodermatitis enteropathica. Before therapy the serum-zinc levels of patients were markedly decreased. After oral application of high doses of zinc aspartate (2×400 mg/day) all clinical symptoms disappeared within a week. The results point at a causal connection between zinc and the pathogenesis of acrodermatitis enteropathica. Ultrastructural alterations of the Paneth cells of the intestine are also shown in this disease [12] as have also been seen in Paneth cells of zinc deficient rats [Beitr. Path. 145, 336 (1972)].
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 4
    ISSN: 1432-1076
    Keywords: Key words Protein quality ; Dietetic treatment ; Phenylketonuria
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract The protein quality of the diets of phenylketonuria (PKU) children of different ages (3 months, 10 months, 3 years, 8 years, 12 years, 16 years) with low or high phenylalanine (Phe) tolerance was assessed according to the recommendations of the FAO/WHO consultation group [13]. The amount of each essential amino acid (AA) per gram dietary protein was calculated and compared to the reference. The resultant amino acid score (AAS) indicated a limited to inadequate biological protein quality of the diets in 3-month-old infants (2.2 g protein/kg body weight/day) and 10-month-old infants (2.0 g protein/kg body weight/day) with a “high” Phe tolerance. In all other age groups the AAS was 〉 100%. However remarkable imbalances in the AA pattern were apparent. Beginning with the age of 3 years (1.7 g protein/kg body weight/day) the intake of the AA lysine and isoleucine was three or two times higher than recommended. At the age of 8 years (1.4 g protein/kg body weight/day) the intake of three AA (valine, isoleucine, lysine) was – related to the WHO recommendations – 217%, 229% and 291%. Similar results could be found in the age groups of 12 years (1.1 g protein/kg body weight/day) and 16 years (0.9 g protein/kg body weight/day), respectively. These calculations might help to reconsider the composition of the AA mixtures used in the dietetic treatment of PKU patients.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...